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The increase of disease outbreaks caused by Vibrio species in aquatic organisms as well as in
humans, together with the emergence of antibiotic resistance in Vibrio species, has led to a growing
interest in alternative disease control measures. Quorum sensing (QS) is a mechanism for
regulating microbial gene expression in a cell density-dependent way. While there is good evidence
for the involvement of auto-inducer 2 (AI-2)-based interspecies QS in the control of virulence in
multiple Vibrio species, only few inhibitors of this system are known. From the screening of a small
panel of nucleoside analogues for their ability to disturb AI-2-based QS, an adenosine derivative
with a p-methoxyphenylpropionamide moiety at C-39 emerged as a promising hit. Its mechanism of
inhibition was elucidated by measuring the effect on bioluminescence in a series of Vibrio harveyi
AI-2 QS mutants. Our results indicate that this compound, as well as a truncated analogue lacking
the adenine base, block AI-2-based QS without interfering with bacterial growth. The active
compounds affected neither the bioluminescence system as such nor the production of AI-2, but
most likely interfered with the signal transduction pathway at the level of LuxPQ in V. harveyi. The
most active nucleoside analogue (designated LMC-21) was found to reduce the Vibrio species
starvation response, to affect biofilm formation in Vibrio anguillarum, Vibrio vulnificus and Vibrio
cholerae, to reduce pigment and protease production in V. anguillarum, and to protect gnotobiotic
Artemia from V. harveyi-induced mortality.
INTRODUCTION
Vibrio species are ubiquitous in marine environments
worldwide (Igbinosa & Okoh, 2008). As opportunistic
pathogens they can cause mild to severe infections in
humans and marine animals. Vibriosis is one of the most
prevalent fish diseases, mainly caused by Vibrio anguil-
larum, Vibrio alginolyticus, Vibrio parahaemolyticus, Vibrio
harveyi and Vibrio campbellii (Garcia et al., 1997; Austin &
Zhang, 2006). Other Vibrio species are pathogenic for
humans. Vibrio vulnificus is associated with gastrointestinal
infections primarily following the consumption of raw
and undercooked seafood, but it can also cause wound or
soft-tissue infections (Bross et al., 2007). In addition,
systemic V. vulnificus infections are notorious for their
high mortality rate (Chiang & Chuang, 2003). Vibrio
cholerae is responsible for pandemic and epidemic out-
breaks of cholera (Griffith et al., 2006). V. cholerae serotype
O1 causes the majority of the outbreaks worldwide, while
the O139 serotype has only been detected in South-East
and East Asia (Sack et al., 2004; Griffith et al., 2006). Cell–
cell communication (quorum sensing; QS) in Vibrio
species plays an important role in virulence. QS in Vibrio
species involves three types of signal molecules. N-
Acylhomoserine lactones (AHLs) are used in the LuxM/N
QS system, cholera auto-inducer 1 (CAI-1) in the CqsA/S
system and auto-inducer 2 (AI-2) in the LuxS/PQ QS
system (Bassler et al., 1993, 1997; Higgins et al., 2007; Ryan
& Dow, 2008). AI-2 is synthesized starting from S-
adenosylmethionine, which (through a series of enzymatic
reactions, including the reaction catalysed by LuxS) is
converted to 4,5-dihydroxy-2,3-pentanedione (DPD)
(Surette et al., 1999; Winzer et al., 2002). The spontaneous
Abbreviations: AI-2, auto-inducer 2; CV, crystal violet; DPD, 4,5-
dihydroxy-2,3-pentanedione; MCPBA, 4-methoxycarbonyl-phenylboro-
nic acid; QS, quorum sensing; QSI, QS inhibiting.
A set of supplementary methods, three supplementary figures and four
supplementary tables are available with the online version of this paper.
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cyclization of DPD followed by esterification with a
tetrahydroxyborate anion results in the formation of AI-2
(Miller et al., 2004). In Vibrio species, sensing of
extracellular AI-2 involves two proteins, LuxP and LuxQ
(Chen et al., 2002). At a low AI-2 concentration, LuxQ will
be autophosphorylated, resulting in the transfer of a
phosphate group to LuxO via LuxU (Freeman & Bassler,
1999a, b). Phosphorylation of LuxO leads to its activation
and the production of small regulatory RNAs. These small
RNAs, together with the chaperone protein Hfq, destabilize
mRNA of the response regulator LuxR. In the absence of
AI-2, LuxR is not produced and LuxR-dependent genes are
not transcribed. Binding of AI-2 to the LuxPQ complex
initiates a switch from kinase to phosphatase activity,
which results in the dephosphorylation of the downstream
proteins LuxU and LuxO. Dephosphorylated LuxO is
inactive and does not induce the production of small
regulatory RNAs. Hence, the response regulator LuxR is
produced and initiates transcription of target genes,
including several virulence genes. Therefore, QS inhibitors
are promising antipathogenic agents. Due to the presence
of the luxS gene in diverse bacterial species, AI-2 is
considered to be a signal for interspecies communication
(Xavier & Bassler, 2003). However, the LuxPQ signal
transduction system is restricted to Vibrionales (Sun et al.,
2004; Rezzonico & Duffy, 2008). The increase of Vibrio
disease outbreaks in aquatic organisms as well as in
humans (Harvell et al., 2002; Boyd et al., 2008; Kapp,
2009), together with the emergence of antibiotic resistance
in Vibrio species (Karunasagar et al., 1994; Scrascia et al.,
2006), has resulted in a growing interest in alternative
disease control measures (Lynch & Wiener-Kronisch,
2008). A novel approach consists of interfering with
bacterial communication (Ni et al., 2009). Several cinna-
maldehyde and furanone derivatives disrupt AI-2-based QS
in Vibrio species by decreasing the DNA-binding activity of
the response regulator LuxR, and are active both in vitro
and in vivo (Defoirdt et al., 2006, 2007; Brackman et al.,
2008). Other compounds, including S-anhydroribosyl-L-
homocysteine and S-homoribosyl-L-cysteine, block the
production of AI-2 by inhibiting the key enzyme LuxS
(Alfaro et al., 2004; Shen et al., 2006). Based on the concept
of molecular mimicry and through virtual screenings using
the crystal structure of LuxP, new AI-2 QS inhibitors have
been discovered (Li et al., 2008; Ni et al., 2008a, b).
However, although these compounds affect biolumin-
escence in V. harveyi, they were evaluated neither for their
effect on QS-regulated virulence factors nor for their
activity in vivo. The goal of the present study was to test
whether previously described AI-2 QS inhibitors targeting
LuxPQ and various compounds from our collection have
the ability to block the production of QS-regulated
virulence factors in Vibrio species.
METHODS
Bacterial strains and growth conditions. All bacterial strains used
in this study are listed in Table 1. They were cultured in Marine-Broth
(MB) (BD) in the presence of appropriate antibiotics at 30 uC with
shaking, except for Escherichia coli DH5a and E. coli K-12, which were
grown in Luria–Bertani broth (LB) (BD) at 30 uC and 37 uC,
respectively, without shaking.
Compound library. The compounds used in the present study
consisted of a selected set of known AI-2 QS inhibitors,
supplemented with a series of nucleoside (mainly adenosine)
analogues (Fig. 1). 39-Azido-(39-N3-39-dA) and 39-amino-39-deox-
yadenosine (39-NH2-39-dA) were prepared as reported by Azhayev &
Smrt (1978), and are nowadays also commercially available. For the
synthesis of the amide analogues derived from 39-NH2-39-dA (i.e.
LMC-23, LMC-20, IK-1, LMC-21, LMC-27 and LMC-28), we
followed the procedure described by Soenens et al. (1995). Briefly,
the 39-amino group of unprotected 39-NH2-39-dA was acylated with
the appropriate carboxylic acids using dicyclohexylcarbodiimide
(DCC) or diisopropylcarbodiimide (DIC) and N-hydroxysuccini-
mide (NHS) as coupling agents in a mixture of dimethylformamide
(DMF) and dichloromethane (see Supplementary Methods and
Supplementary Fig. S1). The synthetic route followed for the
synthesis of the 39 branched-chain analogue SC-23, differing from
that for LMC-21 by the insertion of a CH2 group between C-39 of
the ribofuranose ring and the amide moiety started from the
previously described intermediate 1 (Kim et al., 2003) (see
Supplementary Methods and Supplementary Fig. S2). The 2-
modified adenosine analogues LMC-29, LMC-30 and LMC-35 have
been recently synthesized and found to be potent adenosine A3
receptor antagonists/partial agonists (Cosyn et al., 2006), while PVR-
121 is an agonist for the same receptor (Ohno et al., 2004). The
amides derived from 3-(4-methoxyphenyl)propanoic acid (i.e. SC-1,
SC-2 and SC-3) were prepared by ethyl-3-(3-dimethylaminopro-
pyl)carbodiimide (EDC)-mediated coupling of the parent carboxylic
acid with the appropriate amine in the presence of N,N,N-
triethylamine (TEA). The synthesis of SC-20 started from the
known sugar intermediate 4 (see Supplementary Methods and
Supplementary Fig. S3) that was converted to methyl glycoside
(intermediate 5) upon reaction with SnCl4 and dry methanol
(Moradei et al., 1991). Remarkably, during this reaction, a larger
amount of intermediate 6 was formed. The reaction mixture could
be efficiently separated by flash chromatography, and 5 and 6 were
separately deprotected upon treatment with NH3 in methanol,
thereby yielding 7.1 and 7.2. NMR analysis revealed that 7.1 and 7.2
differ only at the anomeric position (a- or b-keto group). Although
the configuration of each anomer remains uncertain, we anticipate
that 7.1 represents the b-anomer, since it was formed from 5, which
still possessed the participating acetate group at C-2. Subsequently,
we continued with azide 7.2 (presumably the a-anomer), which was
reduced through a Staudinger reduction. Finally, the resulting amine
was coupled to 3-(4-methoxyphenyl)propanoic acid using
N,N,N9,N9,-tetramethyl-O-(6-chloro-1H-benzotriazol-1-yl)uronium
hexafluorophosphate (HCTU) as the coupling agent. All synthesized
compounds were structurally confirmed using 1H and 13C NMR
spectroscopy and exact mass measurements (see Supplementary
Methods) and were shown to possess a purity of at least 95% by
combustion analysis. The previously described AI-2 QS inhibitor 2-
(2-thienylsulfonyl)ethanethioamide (KM-03009) (Li et al., 2008) was
purchased from Acros Organics, while pyrogallol (Ni et al., 2008a)
and 4-methoxycarbonyl-phenylboronic acid (MCPBA) (Ni et al.,
2008b) were purchased from Sigma-Aldrich. If necessary, com-
pounds were diluted in DMSO (final concentration 0.5%, v/v). The
stock solutions were stored at 220 uC. Control solutions contained
the same amount of DMSO.
Determination of MICs.MICs were determined for each compound
by using a microdilution assay, as previously described (Brackman
et al., 2009). MB and LB media were used for all Vibrio species and
both E. coli strains, respectively. The plates were incubated and the
AI-2 quorum-sensing inhibitors
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OD590 was measured after 24 h using a Victor Wallac
2 multilabel
counter (Perkin Elmer Life and Analytical Sciences).
Identification of the molecular target of the QS inhibitors. The
assay for the effect on constitutively expressed bioluminescence
(using E. coli DH5a containing the pBlueLux plasmid), the bioassay
for LuxS inhibition (using V. harveyi MM30) and assays to
determine the molecular target of the compounds tested (using V.
harveyi BB120, BB170, BB886, JAF375, JAF553, JAF483, JMH597
and BNL258) were conducted as described previously (Brackman
et al., 2008). Each compound was tested at least six times in
triplicate (n¢18).
Effect on QS-regulated virulence phenotypes in vitro. The effect
of AI-2 QS inhibitors on pigment production and protease activity in
V. anguillarum LMG 4411 was determined as described previously
(Croxatto et al., 2002). Each compound was tested at least twice in
triplicate (n¢6). Biofilms were grown according to Brackman et al.
(2008). In brief, the Vibrio strains were grown overnight in MB and
approximately 108 c.f.u. ml21 was added to the wells of a 96-well
microtitre plate in the presence or absence of QS inhibiting (QSI)
compounds. Bacteria were allowed to adhere and grow without
agitation for 4 h at 30 uC. After 4 h, plates were emptied and rinsed
with sterile physiological saline (PS). After this rinsing step, fresh MB
(with or without compounds) was added and the plate was incubated
for 20 h at 30 uC.
Biofilm biomass was quantified by crystal violet (CV) staining
(Peeters et al., 2008). The control signal corresponded to an A590 of
0.604±0.108 and 0.639±0.129 for V. anguillarum LMG4411 and V.
vulnificus LMG16867, respectively. For quantification of the number
of metabolically active (i.e. living) cells in the biofilm, a resazurin
assay was used (Peeters et al., 2008). Each compound was tested at
least six times in triplicate (n¢18).
Effect on QS-regulated stress responses in vitro. Vibrio species
were grown overnight in MB, and cells were collected by
centrifugation and resuspended in artificial seawater (ASW) (Bang
et al., 2007). A 1 ml sample of the bacterial suspension was
transferred to 100 ml glass bottles containing 19 ml ASW (with and
without test compound). These suspensions were incubated at 30 uC
without shaking. After 48 h, 1 ml samples were taken and the number
of culturable cells was determined by plating serial dilutions on
tryptic soy agar (TSA) (Oxoid) plates containing 2% (w/v) NaCl.
Results were expressed as numbers of viable cells present after 48 h.
Each assay was repeated at least three times. The effect of the
compounds on the susceptibility towards doxycycline and chlor-
amphenicol of all the Vibrio strains tested was determined as
described previously (Brackman et al., 2008). Each assay was repeated
at least three times. A change in MIC was considered relevant if there
was a shift of more than two doubling dilutions in either direction.
Artemia challenge tests. All experiments were performed with
high-quality hatching cysts of Artemia franciscana shrimps (EG type,
batch 6940, INVE Aquaculture). Cysts (200 mg) were hydrated in
18 ml tap water over 1 h. The procedure of Marques et al. (2004) was
used to obtain sterile decapsulated cysts and nauplii. Challenge tests
(in triplicate) were performed as described previously (Brackman
et al., 2008).
Cytostatic activity assay. The murine (L1210) and human (CEM,
HeLa) cells were seeded at a concentration of 5.0–7.56104 cells per
200 ml in wells of a 96-well microtitre plate in the presence of serial
(fivefold) dilutions of the test compound, using RPMI 1640 culture
medium supplemented with 2 mM L-glutamine, 0.075% (w/v)
NaHCO3, and 10% (w/v) fetal bovine serum. After 48 h (L1210) or
72 h (CEM, HeLa), the cell numbers were determined using a Coulter
Counter (Analis).
Table 1. Strains used in this study
BCCM/LMG, Belgian Co-ordinated Collections/Laboratory of Microbiology collection (Ghent University, Belgium); HPACC, Health Protection
Agency Culture collection.
Strain Additional information Reference or source
V. harveyi strains
BB120 Wild-type from which strains BB170, BB886, MM30, JAF553, JAF483,
BNL258, JAF375 and JMH597 are derived
Bassler et al. (1997)
BB170 luxN : : Tn5 Bassler et al. (1993)
BB886 luxPQ : : Tn5 KanR Bassler et al. (1994)
MM30 luxS : : Tn5 Surette et al. (1999)
JAF553 luxU H58A linked to KanR Freeman & Bassler (1999a)
JAF483 luxO D47A linked to KanR Freeman & Bassler (1999b)
BNL258 hfq : : Tn5lacZ Lenz et al. (2004)
JAF375 luxN : : CmR luxQ : : KanR Freeman & Bassler (1999b)
JMH597 luxN : : Tn5 cqsS : : CmR Defoirdt et al. (2006)
V. anguillarum strain
LMG4411 Isolated from young sea trout (Salmo trutta) BCCM/LMG
V. campbellii strain
LMG21363 Isolated from Penaeus monodon juvenile, lymphoid organ BCCM/LMG
V. cholerae strain
NCTC8457 Isolated from human, biotype El Tor HPACC
V. vulnificus strain
LMG16867 Isolated from tank water on eel farm BCCM/LMG
E. coli strains
DH5apBlueLux Strain (not producing AI-2) containing pBluelux polylinker and luxCDABE genes Brackman et al. (2008)
K12 AI-2-producing strain Ren et al. (2004)
G. Brackman and others
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Statistics. The normal distribution of the data was checked using the
Shapiro–Wilk test. Normally and non-normally distributed data were
analysed using an independent samples t test and the Mann–Whitney
U test, respectively. Statistics were performed using SPSS software,
version 17.0.
RESULTS
Inhibition of AI-2 controlled bioluminescence
The antimicrobial activity of all compounds was evaluated
against all strains used in the present study, and MICs were
found to be higher than 320 mM (160 mM for pyrogallol).
Unless otherwise mentioned, the compounds were used at
a concentration of 40 mM, which is well below the MIC for
all strains tested. Bioluminescence in a constitutively
bioluminescent strain E. coli DH5apBluelux was not
inhibited by any of the compounds tested (see
Supplementary Table S1). The effect on AI-2 QS was
assessed using V. harveyi BB170. LMC-21 was the most
active adenosine derivative and a concentration-dependent
inhibitory effect was observed (Fig. 2). Its isomer LMC-28,
which only differed in the substitution site of the methoxy
group, and SC-20, a truncated ribofuranosyl analogue, also
inhibited AI-2 QS (Fig. 2), but proved significantly weaker
than LMC-21. SC-23 yielded a significant inhibition of QS
in the V. harveyi BB170 reporter strain only when tested at
a concentration above 40 mM (Fig. 2). In addition,
MCPBA, KM-03009 and pyrogallol were able to block
the AI-2 QS system (Fig. 2). None of the other compounds
resulted in a reduction in bioluminescence, even when used
in higher concentrations (up to 160 mM).
Molecular target of the
phenylpropionamidofuranosyl derivatives
To identify the molecular target of the 39-deoxy-39-(4-
methoxyphenylpropionamido)ribofuranosyl derivatives,
bioluminescence assays were conducted using several AI-
2 QS mutants. No inhibitory effects were observed using
the V. harveyi JAF375 and V. harveyi BB886 mutants, while
inhibition was observed using the V. harveyi JMH597
mutant, suggesting an effect on AI-2 QS. The supernatants
of E. coli K-12 treated with the compounds revealed no
difference in AI-2 activity compared with the control.
Furthermore, LMC-21 blocked bioluminescence in V.
harveyi MM30, but not in V. harveyi JAF553, JAF483 or
BNL258, suggesting that the target is located upstream of
the mutations in the AI-2 signal transduction pathway and
most likely is the LuxPQ complex in V. harveyi. Similar
Fig. 1. Overview of all analogues used in this study and not previously investigated in the context of QS or biofilm inhibitory
activity (a, b and c), and compounds previously only investigated for their effect on AI-2 QS (d). (a) Sugar-modified nucleosides.
(b) Base-modified nucleosides. (c) Simplified analogues derived from LMC-21. (d) Other AI-2 QSI compounds.
AI-2 quorum-sensing inhibitors
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results were obtained with SC-23, LMC-28, MCPBA and
KM03009, suggesting that these molecules also target
LuxPQ.
Effect on protease activity and pigment
production
LMC-21 significantly decreased pigment production by V.
anguillarum LMG4411 after 48 h of growth, but none of
the other compounds tested was able to significantly alter
pigment production (Table 2). Addition of LMC-21,
MCPBA or pyrogallol resulted in a significantly decreased
V. anguillarum LMG4411 protease activity (Table 2).
Effect on in vitro-grown biofilms
The effect of the AI-2 QS inhibitors on the number of
metabolically active cells in the biofilms of several Vibrio
strains was evaluated using a resazurin assay. This assay
revealed no significant decrease in the number of
metabolically active cells in the biofilms of the different
Vibrio strains following treatment (see Supplementary
Fig. 2. Bioluminescence in V. harveyi BB170 in the absence (control) and presence of QS inhibitors. Bioluminescence
measurements were performed 6 h after the addition of the compounds. Bioluminescence of the control (without addition of
compound) was set at 100% and the responses for other samples were normalized accordingly. Error bars, SD.
Bioluminescence was significantly lower than that of the untreated control for all compounds (P,0.05).
Table 2. Effect of the AI-2 QS inhibitors (40 mM) on QS-regulated phenotypes
Compound Protease activity,*
V. anguillarum LMG4411
Pigment production,D
V. anguillarum LMG4411
Biofilm formationd
V. anguillarum LMG4411 V. vulnificus LMG16867
LMC-21 23±3%§ 19±10%§ 35±11%§ 17±15%§
KM-03009 5±12% 2±13% 2±22% 5±24%
MCPBA 20±2%§ 5±16% 36±8%§ 18±16%§
Pyrogallol 18±5%§ 10±22% 10±10% 40±9%§
*Percentage reduction in protease activity compared with an untreated control (A590 1.230±0.132) (mean±SD).
DPercentage reduction in pigment production compared with an untreated control (A405 0.480±0.090) (mean±SD).
dPercentage reduction in biofilm biomass (CV staining) compared with an untreated control (mean±SD).
§Significantly different compared with an untreated control (P,0.05; independent samples t test).
G. Brackman and others
4118 Microbiology 155
Downloaded from www.microbiologyresearch.org by
IP:  193.191.134.1
On: Fri, 21 Sep 2018 09:01:34
Table S2). In contrast, several compounds decreased the
CV staining of V. anguillarum LMG 4411 and V. vulnificus
LMG16867 biofilms (Table 2). However, no significant
anti-biofilm effects were observed for V. harveyi BB120 and
V. campbellii LMG21363. In addition, the use of LMC-21
yielded a minor but significant increase in the CV signal for
V. cholerae El Tor NCTC8457 (15±8% compared with the
untreated control).
Effect on susceptibility of Vibrio species to stress
The effect of the different compounds on the starvation
response and on the antimicrobial susceptibility of the
different Vibrio species was investigated. Upon treatment
with LMC-21, cell numbers significantly decreased in all
Vibrio species (Table 3). Treatment with MCPBA, pyro-
gallol and KM-03009 reduced the number of culturable
cells in some Vibrio species only (Table 3). There were no
significant differences in the MICs for all Vibrio strains
tested for chloramphenicol and doxycycline when used
alone or in combination with a QS inhibitor (see
Supplementary Tables S3 and S4).
Effect on virulence in vivo and cytotoxicity
High mortality rates were observed when Artemia shrimps
were exposed to V. harveyi BB120, but LMC-21 was able to
completely protect Artemia during bacterial challenge (Fig.
3). LMC-21 alone had an effect neither on Artemia (Fig. 3)
nor on V. harveyi BB120 (data not shown). In addition,
LMC-21 was found to have IC50 values ¢250 mM (L1210
cells) or ¢125 mM (CEM and HeLa cells).
DISCUSSION
QS is an important regulator of bacterial virulence in some
bacterial species. Accordingly, QS inhibition is gaining
interest as a potential alternative strategy for the treatment
of bacterial infections. Although LuxS appears to be
omnipresent in the bacterial world, the LuxPQ signal
transduction system is restricted to Vibrionales (Sun et al.,
2004; Rezzonico & Duffy, 2008). This makes the AI-2
receptor complex of Vibrionales an interesting target for
the selective control of Vibrio species QS-regulated
virulence.
In this study, we not only confirmed the QS inhibitory
activity of several established AI-2 QS inhibitors but also
discovered several new inhibitors. To identify their
molecular target, we evaluated the effect of the most active
compound (LMC-21) on different V. harveyi QS mutants.
Although we originally anticipated that certain adenosine
analogues might disturb the biosynthesis of DPD, due to
their structural similarity to S-adenosylmethionine, our
data indicate that LMC-21 exerts its effect at the level of the
AI-2 transduction system rather than that of AI-2
production. For these experiments, several V. harveyi QS
mutants with mutations in the AI-2 signal transduction
system were used. V. harveyi JAF553 and JAF483 contain a
point mutation in the luxU and luxO genes, respectively,
thereby preventing the phosphorelay capacity of LuxU and
LuxO. V. harveyi BNL258 has a Tn5 insertion in the hfq
gene, resulting in a non-functional Hfq protein. Since V.
harveyi strains JAF553, JAF483 and BNL258 are all
constitutively luminescent, a lack of inhibition of bio-
luminescence in one of these strains indicates that the
inhibitor acts upstream of the mutated protein. Our
compound proved incapable of blocking bioluminescence
in these three QS mutants. This suggests that the target of
the 3-(methoxyphenylpropionamido)ribofuranosyl deriva-
tives is the upstream component of the AI-2 signalling
transduction pathway, LuxPQ. In addition, no effect was
observed when testing the compound in V. harveyi BB886,
a mutant which lacks the LuxP receptor required for the
AI-2 response, and in V. harveyi JAF375, a mutant which
lacks LuxQ. Although several compounds inhibit the AI-2
QS system, there are few reports of QS inhibitors targeting
LuxPQ. Phenylboronic acids, pyrogallol derivatives and 2-
(2-thienylsulfonyl)ethanethioamide, previously reported to
block the AI-2 QS system at the level of LuxPQ (Li et al.,
2008; Ni et al., 2008a, b), were at best as active as LMC-21.
Table 3. Effect of the AI-2 QS inhibitors (40 mM) on the QS-regulated starvation response
Data are presented as numbers of viable cells (6108) present after 48 h.
Compounds Number of viable cells (108) (mean±SD)
V. anguillarum
LMG4411
V. campbellii
LMG21363
V. cholerae
NCTC8457
V. harveyi BB120 V. vulnificus
LMG16867
Initial number of cells 1.05±0.30 1.00±0.23 1.16±0.11 1.15±0.14 1.11±0.21
Control 0.77±0.25 0.91±0.18 1.10±0.07 1.19±0.45 1.09±0.21
LMC-21 0.08±0.07* 0.47±0.09* 0.86±0.12* 0.53±0.43* 0.67±0.01*
KM-03009 0.58±0.07 0.93±0.46 0.94±0.45 0.85±0.16* 1.11±0.17
MCPBA 0.32±0.17* 1.02±0.32 1.24±0.66 1.17±0.37 0.93±0.11
Pyrogallol 0.21±0.04* 0.56±0.15* 0.91±0.13 1.22±0.67 1.03±0.05
*Significantly different from the number of cells present after 48 h in the control (P,0.05; Mann–Whitney U test).
AI-2 quorum-sensing inhibitors
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None of these compounds has been previously evaluated
for its effect on AI-2-related virulence. One molecule from
each group of LuxPQ inhibitors was selected for further
experiments. LMC-21 was able not only to reduce pigment
production in V. anguillarum LMG4411 but also to
decrease protease activity in this strain. In contrast, none
of the established QS inhibitors targeting LuxPQ was able
to block pigment production or to reduce protease more
than did LMC-21. In addition, LMC-21 decreased the
biofilm biomass of V. anguillarum and V. vulnificus,
without reducing the number of viable cells present in
the biofilms. Pyrogallol only decreased biofilm biomass in
V. vulnificus, but to a higher extent than LMC-21. These
data confirm the finding that pigment and protease
production in V. anguillarum and biofilm formation in
V. anguillarum, V. vulnificus and V. cholerae are (at least
partially) controlled by the AI-2 QS system (Croxatto et al.,
2002; Zhu et al., 2002; Hammer & Bassler, 2003; Lee et al.,
2007; Brackman et al., 2008). Mutations in the LuxR
homologues of V. anguillarum (VanT) and V. vulnificus
(SmcR) have been shown to reduce biofilm formation in
these species, indicating that AI-2 QS promotes biofilm
formation in these species (Croxatto et al., 2002; Lee et al.,
2007). In contrast, V. cholerae HapR represses the
expression of vps genes (involved in the production of
exopolysaccharides) and biofilm formation (Zhu et al.,
2002; Hammer & Bassler, 2003), indicating that AI-2 QS
negatively influences biofilm formation in this species.
However, the main QS signalling molecule in V. cholerae is
CAI-1, and this may explain the limited effect of AI-2 QS
inhibitors on V. cholerae biofilm formation. Whether the
increase in V. cholerae biomass, due to LMC-21, would
impose problems in in vivo situations remains to be
determined. In addition, Vibrio species are also known to
regulate stress adaptation by means of their QS system. AI-
2 is capable of regulating different stress responses,
including starvation in V. cholerae, V. vulnificus, V.
anguillarum and Vibrio angustum (McDougald et al.,
2001, 2003; Larsen et al., 2004; Joelsson et al., 2007; Lee
et al., 2007; Weber et al., 2008). Our data indicate that
LMC-21 suppresses the QS-regulated starvation response
in all Vibrio species examined, while the other compounds
increase susceptibility to starvation-associated stress con-
ditions in some Vibrio species only, and to a lesser extent
than LMC-21. However, our results indicate that AI-2
inhibition in five Vibrio species did not change their
antimicrobial susceptibility. Of all the compounds tested,
LMC-21 was the most interesting, since it was clearly at
least as active in inhibiting in vitro virulence as the other
active compounds tested in this study. Although a decrease
in virulence in vitro is not always linked to a decrease in
virulence in vivo, LMC-21 was shown to be a potent
suppressor of V. harveyi BB120 virulence in vivo. LMC-21
alone had no effect on Artemia survival, and its lack of
cytotoxicity, when used at 40 mM, was confirmed using
murine and human cell lines. It is interesting to note that
halogenated furanones, well-documented QS inhibitors,
have toxic side-effects in concentrations comparable to
those used in the present study (Defoirdt et al., 2006;
Janssens, 2008).
Fig. 3. Effect of LMC-21 on the survival of Artemia. Control: survival of Artemia without challenge with V. harveyi BB120 and
without LMC-21. Control+LMC-21: survival of Artemia without challenge with V. harveyi BB120 in the presence of LMC-21
(40 mM). V. harveyi BB120: survival of Artemia after challenge with V. harveyi BB120 in the absence of LMC-21. V. harveyi
BB120+LMC-21: survival of Artemia after challenge with V. harveyi BB120 and treatment with LMC-21 (40 mM). Asterisks
indicate survival significantly different from treatment with pathogen alone (P,0.001).
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In a preliminary search for the active pharmacophore of
LMC-21, we synthesized two compounds based on the
phenylpropionamidofuranosyl backbone. Based on their
effect on AI-2-regulated bioluminescence in V. harveyi
BB120, we identified the most important structural
elements required for achieving QS inhibition. Minor
changes, e.g. removing the methoxy group from the para
(LMC-21) to the meta position (LMC-28), or the insertion
of an extra CH2 group between the phenylpropionamido
substituent and the ribose moiety (SC-23), resulted in a
decreased activity. Other molecules strongly resembling
LMC-21, e.g. LMC-20 (longer side chain), LMC-23
(lacking the methoxy-substituted aromatic ring), LMC-27
(lacking the methoxy substitution on the aromatic ring)
and IK-1, failed to inhibit the AI-2 QS system, and together
point toward a specific (receptor-mediated) effect. We also
investigated the importance of the adenine moiety present
in LMC-21 by evaluating the effect of SC-1, SC-2, SC-3 and
SC-20. Only SC-20 inhibited AI-2 QS, clearly showing that
the ribofuranose moiety is required for activity. In
addition, these results show that although an adenine
group is not essential for activity, its presence results in
more active compounds. However, the molecular inter-
action of these compounds with LuxPQ remains to be
determined.
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